As a result, there have been numerous attempts to establish a set of guidelines for an early liver cancer diagnosis and long-term prognosis based on different serum biomarkers such as alpha-fetoprotein (AFP), des-gamma-carboxy-prothrombin (DCP) or other novel markers that are currently being studied [1]. The gene discussed is AFP; the disease is liver cancer.